Calendar Cryo-Cell International, Inc.

Equities

CCEL

US2288951088

Market Closed - Nyse 04:10:00 2024-04-26 pm EDT 5-day change 1st Jan Change
8.45 USD +8.33% Intraday chart for Cryo-Cell International, Inc. +12.67% +46.96%

Chart calendar Cryo-Cell International, Inc.

3.IKxAwMLX1kvvxhJsLKBkrt89wyS6yoyacjgHNrWXSlU.dfMxuvGDmiSjsmYlYNom4oxvtGbUqe_ZHUJfbNzCPzRK_XH2po-OeoSJJg~ddfe76a2a1c771f7bbd81d3392ee216f

Upcoming events on Cryo-Cell International, Inc.

2024-07-11 Q2 2024 Earnings Release (Projected)
2024-10-10 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)
2025-04-20 Q1 2025 Earnings Release (Projected)

Past events on Cryo-Cell International, Inc.

2024-04-15 05:00 pm Q1 2024 Earnings Release
2024-02-28 05:00 pm Q4 2023 Earnings Release
2024-01-24 11:30 am Maxim Group Virtual Healthcare IT Conference
2023-10-12 04:45 pm Q3 2023 Earnings Release
2023-10-10 11:00 am Annual General Meeting
2023-07-14 04:15 pm Q2 2023 Earnings Release
2023-02-28 05:15 pm Q4 2022 Earnings Release
2022-10-14 04:15 pm Q3 2022 Earnings Release
2022-10-02 Annual General Meeting
2022-08-31 Ex-dividend day
2022-07-11 04:30 pm Interim 2022 Earnings Release
2022-04-13 04:30 pm Q1 2022 Earnings Release
2022-02-22 04:30 pm FY 2021 Earnings Release
2021-12-05 Winter Virtual Prego Expo
2021-10-20 10:00 am Annual General Meeting
2021-10-15 04:36 pm Q3 2021 Earnings Release
2021-09-12 Fall Virtual Prego Expo
2021-08-18 02:45 pm Q3 Virtual Investor Summit
2021-07-15 07:27 pm Interim 2021 Earnings Release
2021-06-06 Summer Virtual Prego Expo

Past dividends on Cryo-Cell International, Inc.

2022-08-31 0.9 USD

Annual results

Fiscal PeriodNovember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00


30,3
29,8
1.67%
31,3
31,4
-0.12%

31,8

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00


6,04
5,95
1.49%
0,00
5,57
-

3,23

EBIT
Million USD
Released
Forecast
Spread
0,00


0,00


4,02
3,93
2.3%
-12,3
3,48
-454.07%

2,38

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00


3,32
2,49
33.08%
-13,4
1,73
-871.62%

0,35

Net income
Million USD
Released
Forecast
Spread
3,62


2,08


2,77
1,79
55%
-9,52
1,02
-1030.76%

0,24

EPS
USD
Released
Forecast
Spread
0,45


0,25


0,33
0,13
153.85%
-1,14
0,12
-1050%

0,03

Announcement Date01/03/2122/02/2228/02/2328/02/24-

Quarterly results

Fiscal Periodnovember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread



7,70
7,40
4.05%
7,76
7,26
6.88%
7,82
7,41
5.56%
7,77
7,77
0.02%
7,87
7,77
1.31%
7,88
7,91
-0.46%
7,85
7,93
-1.01%

7,95


8,03


7,94


7,95


8,13

EBITDA
Million USD
Released
Forecast
Spread



1,24
0,70
76.6%
1,01
0,92
9.69%
1,89
0,67
181.43%
1,33
0,24
450.45%
1,56
0,48
226.04%

0,28

0,90
0,93
-2.9%

1,03


0,51


0,48


1,15


1,07

EBIT
Million USD
Released
Forecast
Spread



0,95
0,34
179.86%
0,41
0,32
28.69%
1,68
-0,01
33763.4%
1,03
-0,43
336.84%
1,16
-0,20
692.37%
-16,2
-0,40
-3974.6%
0,82
0,23
253.97%

0,87


0,35


0,33


0,99


0,92

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



0,64
-0,05
1356.8%
0,62
-0,20
408.17%
1,21
-0,48
350.94%
0,35
-0,90
138.32%
1,07
-0,67
259.58%
-16,0
-0,90
-1684.94%
0,79
-0,20
497.26%

0,41


-0,41


-0,44


0,22


0,24

Net income
Million USD
Released
Forecast
Spread
0,63


0,47
-0,04
1361.68%
0,84
-0,15
673.85%
0,77
-0,35
320.4%
0,22
-0,65
133.94%
0,68
-0,48
241.2%
-11,2
-0,65
-1634.89%
0,56
-0,14
486.28%

0,30


-0,30


-0,32


0,16


0,17

EPS
USD
Released
Forecast
Spread
0,07


0,06
0,00
-
0,10
-0,02
600%
0,09
-0,04
325%
0,03
-0,08
137.5%
0,08
-0,06
233.33%
-1,34
-0,08
-1575%
0,07
-0,02
450%

0,04


-0,04


-0,04


0,02


0,02

Announcement Date11/07/2214/10/2228/02/2321/04/2314/07/2312/10/2328/02/2415/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CCEL Stock
  4. Calendar Cryo-Cell International, Inc.